Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I

Radiation Protection Dosimetry

Volumn 118, Issue 1, 2006, Pages 22-27

  Pant, G S ^a   Sharma, S K ^a   Bal, C S ^a   Kumar, Rakesh ^a   Rath, G K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ARTICLE; CLINICAL ARTICLE; FAMILY ASSESSMENT; HUMAN; RADIATION ABSORPTION; RADIATION DOSE; RADIATION MEASUREMENT; RADIATION MONITORING; RADIATION PROTECTION; RADIATION SAFETY; THERMOLUMINESCENCE DOSIMETER; THERMOLUMINESCENCE DOSIMETRY; THYROID CANCER; THYROTOXICOSIS; WHOLE BODY RADIATION;

ENVIRONMENTAL EXPOSURE; FAMILY; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; RADIATION DOSAGE; RADIATION MONITORING; RADIATION PROTECTION; RISK FACTORS; THERMOLUMINESCENT DOSIMETRY; THYROID NEOPLASMS;

EID: 33646855550     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/nci337     Document Type: Article

References (22)

1. Schlumberger, M. J. Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 338, 297-306 (1998).
2. Harbert, J. C. and Wells, N. Radiation exposure to the family of radioactive patients. J. Nucl. Med. 15(10), 887-888 (1974).
3. Sulaiman, B. T. and Clarke, S. E. Radiation doses to patient's relatives following radioiodine. Med. J. Malaysia 51(1), 131-133 (1996).
4. 131I therapy in Europe. Thyroid 7(2), 221-224, (1997).
5. Barrington, S. F., O'Doherty, M. J., Kettle, A. G. and Mountford, P. J. Dose rate measurements combined with social behavior model enables estimation of potential radiation hazards to families of patients treated with radioiodine. Health Phys. 78(1), 100-101 (2000).
6. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60 (Oxford: Pergamon Press) (1991).
7. Mountford, P. J. and O'Doherty, M. J. Restrictions following iodine-131 treatment - a time for change or more data required? Eur. J. Nucl. Med. 21, 903-905 (1994).
8. 4:DY TLD. Radiat. Prot. Dosim. 100, 337-339 (2002).
9. 4:DY. Teflon TLD discs. Phys. Med. Biol. 24, 999-1008 (1979).
10. 131I therapy. Thyroid 7(2), 199-204 (1997).
11. AERB Safety code. Safety code for nuclear medicine facilities. AERB/SC/ MED-4 (2004).
12. O'Doherty, M. J., Kette, A. G., Eustance, C. N. P., Mountford, P. J. and Coakley, A. J. Radiation dose rates from adult patients receiving I-131 therapy for thyrotoxicosis. Nucl. Med. Commun. 14, 160-168 (1993).
13. Wasserman, H. J. and Klopper, J. F. Analysis of radiation doses received by public from I-131 treatment of thyrotoxicosis outpatients. Nucl. Med. Commun. 14, 756-760, (1993).
14. Leslie, W. D., Havelock, J., Palser, R. and Abrams, D. N. Large body radiation doses following radioiodine therapy. Nucl. Med. Commun. 23, 1091-1097 (2002).
15. Mathieu, I., Caussin, J. and Beckers, C. Regulations and policies on radioiodine (I-131) therapy in Europe. Thyroid, 7, 221-224 (1997).
16. International Atomic Energy agency. International basic safety standards for protection against ionising radiation and for the safety of radioactive sources. IAEA Safety Series, No. 115. (Vienna: IAEA) (1996).
17. European Commission. Radiation Protection 97: Radiation protection following iodine-131 therapy (exposure due to out patient or discharged in patients). Office for offical publications of the European committees, Luxembourg, Belgium (1998).
18. US Nuclear Regulatory Commission. Regulatory guide 8.39: Release of patients administered radioactive material. US Nuclear Regulatory Commission, Washington DC (1997).
19. The Code of Federal Regulations. Title 10, criteria for the release of individuals administered radioactive material. Fed. Regist. 62, 4122-4123 (1997).
20. 131I in outpatients: A simplified method conforming to the Code of Federal Regulations, Title 10, Part 35.75. J. Nucl. Med. 41(11), 1868-1875 (2000).
21. International Commission on Radiological Protection. Annual limits on intake of radionuclides by workers based on the 1990 recommendations. ICRP Publication 51. Ann. ICRP 21 (1991).
22. Lassmann, M., Hanscheild, H., Shelper, L. F., Korber, C. and Reiners, C. Measurement of incorporation in family members of radioiodine therapy patients after of benign thyroid diseases. Nuklearmedizin 37(3), 120-123 (1998).